 Dana Swenson
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemorrhagic Fever, Ebola | 13 | 2018 | 81 | 1.210 |
Why?
| | Ebolavirus | 15 | 2015 | 89 | 1.160 |
Why?
| | Marburgvirus | 9 | 2015 | 21 | 1.030 |
Why?
| | Marburg Virus Disease | 7 | 2015 | 11 | 0.830 |
Why?
| | Viral Vaccines | 9 | 2015 | 107 | 0.790 |
Why?
| | Virion | 6 | 2018 | 111 | 0.570 |
Why?
| | Filoviridae | 4 | 2008 | 27 | 0.400 |
Why?
| | Morpholines | 3 | 2009 | 128 | 0.390 |
Why?
| | Antigens, Viral | 3 | 2008 | 182 | 0.390 |
Why?
| | Ebola Vaccines | 3 | 2018 | 13 | 0.380 |
Why?
| | Antibodies, Viral | 7 | 2018 | 672 | 0.300 |
Why?
| | Oligonucleotides, Antisense | 1 | 2009 | 116 | 0.280 |
Why?
| | Virosomes | 1 | 2008 | 2 | 0.280 |
Why?
| | Antiviral Agents | 3 | 2015 | 767 | 0.270 |
Why?
| | Adenoviridae | 1 | 2008 | 199 | 0.250 |
Why?
| | Genetic Vectors | 1 | 2008 | 337 | 0.240 |
Why?
| | Viral Matrix Proteins | 2 | 2005 | 29 | 0.220 |
Why?
| | Macaca fascicularis | 5 | 2018 | 71 | 0.220 |
Why?
| | Viral Envelope Proteins | 2 | 2005 | 98 | 0.210 |
Why?
| | Filoviridae Infections | 3 | 2010 | 8 | 0.210 |
Why?
| | Guinea Pigs | 3 | 2008 | 159 | 0.140 |
Why?
| | Vaccination | 4 | 2018 | 1423 | 0.130 |
Why?
| | Morpholinos | 2 | 2015 | 29 | 0.130 |
Why?
| | Animals | 21 | 2018 | 38058 | 0.120 |
Why?
| | Vero Cells | 4 | 2009 | 84 | 0.120 |
Why?
| | Membrane Glycoproteins | 4 | 2007 | 496 | 0.120 |
Why?
| | Viral Proteins | 3 | 2007 | 355 | 0.120 |
Why?
| | Viremia | 2 | 2008 | 158 | 0.120 |
Why?
| | Receptors, Immunologic | 2 | 2007 | 206 | 0.110 |
Why?
| | Nucleoproteins | 3 | 2018 | 38 | 0.110 |
Why?
| | Mycobacterium tuberculosis | 3 | 2004 | 334 | 0.100 |
Why?
| | Dendritic Cells | 2 | 2007 | 499 | 0.100 |
Why?
| | Virus Replication | 4 | 2009 | 529 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 2027 | 0.080 |
Why?
| | Viral Plaque Assay | 2 | 2008 | 29 | 0.080 |
Why?
| | Isocitrate Lyase | 2 | 2000 | 2 | 0.080 |
Why?
| | Mice, Inbred C57BL | 8 | 2009 | 5992 | 0.080 |
Why?
| | Glycoproteins | 2 | 2018 | 355 | 0.080 |
Why?
| | Vaccines, Synthetic | 1 | 2010 | 138 | 0.080 |
Why?
| | Cell Line | 5 | 2007 | 2882 | 0.080 |
Why?
| | Microscopy, Electron | 3 | 2004 | 415 | 0.070 |
Why?
| | Mice, Inbred BALB C | 4 | 2005 | 1253 | 0.070 |
Why?
| | Disease Models, Animal | 5 | 2015 | 4557 | 0.070 |
Why?
| | Viral Core Proteins | 2 | 2005 | 22 | 0.070 |
Why?
| | Animal Structures | 1 | 2008 | 11 | 0.070 |
Why?
| | Vaccines, Inactivated | 1 | 2008 | 70 | 0.070 |
Why?
| | Bioterrorism | 1 | 2008 | 31 | 0.070 |
Why?
| | Alkylating Agents | 1 | 2007 | 24 | 0.070 |
Why?
| | Vacuoles | 1 | 2007 | 38 | 0.070 |
Why?
| | Rabbits | 1 | 2009 | 648 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2009 | 570 | 0.070 |
Why?
| | Azides | 1 | 2007 | 47 | 0.070 |
Why?
| | Mice | 9 | 2009 | 18339 | 0.070 |
Why?
| | Sequence Alignment | 1 | 2008 | 366 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2008 | 2155 | 0.060 |
Why?
| | Bacillus anthracis | 1 | 2006 | 13 | 0.060 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 2930 | 0.060 |
Why?
| | Antisense Elements (Genetics) | 1 | 2006 | 3 | 0.060 |
Why?
| | Neutrophil Activation | 1 | 2006 | 85 | 0.060 |
Why?
| | Technology, Pharmaceutical | 1 | 2005 | 30 | 0.060 |
Why?
| | Transfection | 2 | 2005 | 940 | 0.050 |
Why?
| | Killer Cells, Natural | 2 | 2007 | 467 | 0.050 |
Why?
| | Survival Analysis | 1 | 2008 | 1382 | 0.050 |
Why?
| | Phagosomes | 1 | 2004 | 40 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2018 | 561 | 0.050 |
Why?
| | Bacterial Proteins | 2 | 2000 | 955 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 851 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2007 | 4154 | 0.050 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2005 | 917 | 0.040 |
Why?
| | RNA, Viral | 3 | 2015 | 688 | 0.040 |
Why?
| | Neutrophils | 1 | 2006 | 1134 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 1499 | 0.040 |
Why?
| | Mycobacterium avium | 1 | 1999 | 21 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1716 | 0.040 |
Why?
| | Transcription Factors | 1 | 2007 | 1741 | 0.040 |
Why?
| | Macaca mulatta | 2 | 2010 | 191 | 0.030 |
Why?
| | Tuberculosis | 1 | 2000 | 291 | 0.030 |
Why?
| | Mutation | 2 | 2007 | 4089 | 0.030 |
Why?
| | Humans | 12 | 2015 | 144759 | 0.030 |
Why?
| | Macrophages | 2 | 2004 | 1511 | 0.030 |
Why?
| | Viral Regulatory and Accessory Proteins | 2 | 2006 | 27 | 0.030 |
Why?
| | Perforin | 2 | 2007 | 21 | 0.030 |
Why?
| | Pore Forming Cytotoxic Proteins | 2 | 2007 | 15 | 0.030 |
Why?
| | Cross Protection | 1 | 2015 | 5 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2007 | 223 | 0.030 |
Why?
| | Female | 7 | 2009 | 78271 | 0.030 |
Why?
| | Macaca | 1 | 2015 | 65 | 0.030 |
Why?
| | Immunity, Humoral | 1 | 2015 | 120 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2009 | 11679 | 0.030 |
Why?
| | Mutagenesis | 2 | 2007 | 192 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 965 | 0.020 |
Why?
| | Interferon-gamma | 2 | 2005 | 784 | 0.020 |
Why?
| | Kidney | 2 | 2007 | 1495 | 0.020 |
Why?
| | Kinetics | 2 | 2006 | 1627 | 0.020 |
Why?
| | Primates | 1 | 2010 | 132 | 0.020 |
Why?
| | Safety | 1 | 2010 | 356 | 0.020 |
Why?
| | Democratic Republic of the Congo | 1 | 2007 | 33 | 0.020 |
Why?
| | Haplorhini | 1 | 2007 | 52 | 0.020 |
Why?
| | Cytokines | 2 | 2007 | 2061 | 0.020 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 1 | 2007 | 46 | 0.020 |
Why?
| | Rodentia | 1 | 2007 | 61 | 0.020 |
Why?
| | Natural Cytotoxicity Triggering Receptor 1 | 1 | 2007 | 3 | 0.020 |
Why?
| | Natural Cytotoxicity Triggering Receptor 2 | 1 | 2007 | 2 | 0.020 |
Why?
| | Natural Cytotoxicity Triggering Receptor 3 | 1 | 2007 | 2 | 0.020 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2007 | 141 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2007 | 60 | 0.020 |
Why?
| | Photochemistry | 1 | 2007 | 134 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2832 | 0.020 |
Why?
| | K562 Cells | 1 | 2007 | 93 | 0.020 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2006 | 7 | 0.020 |
Why?
| | DNA Primers | 1 | 2007 | 512 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2007 | 321 | 0.020 |
Why?
| | Spores, Bacterial | 1 | 2006 | 19 | 0.020 |
Why?
| | Male | 3 | 2009 | 72315 | 0.010 |
Why?
| | Colony Count, Microbial | 1 | 2006 | 122 | 0.010 |
Why?
| | Cross Reactions | 1 | 2006 | 130 | 0.010 |
Why?
| | Protein Transport | 1 | 2007 | 441 | 0.010 |
Why?
| | Bacteriological Techniques | 1 | 2006 | 68 | 0.010 |
Why?
| | Mice, Knockout | 2 | 2005 | 3121 | 0.010 |
Why?
| | Saponins | 1 | 2005 | 11 | 0.010 |
Why?
| | Nucleocapsid Proteins | 1 | 2005 | 28 | 0.010 |
Why?
| | Cell Death | 1 | 2007 | 383 | 0.010 |
Why?
| | Vaccines, Subunit | 1 | 2005 | 53 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2006 | 342 | 0.010 |
Why?
| | Neutralization Tests | 1 | 2004 | 76 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 2004 | 164 | 0.010 |
Why?
| | Colloids | 1 | 2004 | 61 | 0.010 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2005 | 175 | 0.010 |
Why?
| | Cell Membrane | 1 | 2007 | 706 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 2004 | 168 | 0.010 |
Why?
| | Vaccines, Attenuated | 1 | 2004 | 129 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 983 | 0.010 |
Why?
| | Adjuvants, Immunologic | 1 | 2005 | 245 | 0.010 |
Why?
| | Microscopy, Atomic Force | 1 | 2004 | 134 | 0.010 |
Why?
| | Gold | 1 | 2004 | 115 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 2006 | 477 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2006 | 427 | 0.010 |
Why?
| | Antibody Formation | 1 | 2004 | 294 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2007 | 1173 | 0.010 |
Why?
| | Interleukin-2 | 1 | 2004 | 437 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1054 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2006 | 458 | 0.010 |
Why?
| | Spleen | 1 | 2004 | 508 | 0.010 |
Why?
| | Phosphorylation | 1 | 2006 | 1732 | 0.010 |
Why?
| | Immunity, Innate | 1 | 2006 | 846 | 0.010 |
Why?
| | Peptides | 1 | 2006 | 995 | 0.010 |
Why?
| | Sepsis | 1 | 2006 | 640 | 0.010 |
Why?
| | Palmitates | 1 | 1999 | 21 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2006 | 1166 | 0.010 |
Why?
| | Succinic Acid | 1 | 1999 | 42 | 0.010 |
Why?
| | Acetates | 1 | 1999 | 80 | 0.010 |
Why?
| | Immunotherapy | 1 | 2004 | 653 | 0.010 |
Why?
| | Genotype | 1 | 2004 | 1833 | 0.010 |
Why?
| | Virulence | 1 | 2000 | 278 | 0.010 |
Why?
| | Macrophage Activation | 1 | 2000 | 193 | 0.010 |
Why?
| | Open Reading Frames | 1 | 1999 | 132 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 299 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 540 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 269 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2004 | 1129 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 675 | 0.010 |
Why?
| | Fatty Acids | 1 | 2000 | 450 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1999 | 1370 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 3162 | 0.010 |
Why?
| | Escherichia coli | 1 | 1999 | 854 | 0.010 |
Why?
| | Inflammation | 1 | 2006 | 2878 | 0.010 |
Why?
| | Time Factors | 1 | 2004 | 7173 | 0.010 |
Why?
| | Lung | 1 | 2000 | 4109 | 0.000 |
Why?
|
|
Swenson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|